Based on the murine model mimicking FGFR2 fusion (FF)-driven ICC pathogenesis, this study demonstrated that the FF oncogenic activity in ICC required the activation of a downstream effector called MEK. The gene discussed is MAP2K7; the disease is intrahepatic cholangiocarcinoma.